MML Investors Services
EBS icon

MML Investors Services’s Emergent Biosolutions EBS Stock Holding History

MML Investors Services’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-17,139
Closed -$164K – 2715
2024
Q4 		$164K Buy
+17,139
New +$157K ﹤0.01% 2557
2022
Q1 		– Sell
-4,826
Closed -$210K – 2077
2021
Q4 		$210K Sell
4,826
-1,922
-28% -$86.9K ﹤0.01% 1901
2021
Q3 		$338K Buy
6,748
+2,493
+59% +$151K ﹤0.01% 1575
2021
Q2 		$268K Buy
4,255
+916
+27% +$58.8K ﹤0.01% 1671
2021
Q1 		$310K Sell
3,339
-1,254
-27% -$128K ﹤0.01% 1498
2020
Q4 		$412K Buy
4,593
+319
+7% +$29.3K ﹤0.01% 1257
2020
Q3 		$442K Buy
4,274
+675
+19% +$72.8K 0.01% 1098
2020
Q2 		$285K Buy
+3,599
New +$268K ﹤0.01% 1237
2019
Q2 		– Sell
-4,030
Closed -$204K – 1609
2019
Q1 		$204K Buy
4,030
+434
+12% +$25.6K ﹤0.01% 1478
2018
Q4 		$213K Buy
+3,596
New +$232K ﹤0.01% 1344

Other funds holding EBS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
OHA
Oak Hill Advisors New York $878M AUM 106.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

MML Investors Services's EBS Position: Q1 2025 in Review

MML Investors Services sold out of Emergent Biosolutions (EBS) in Q1 2025, closing a stake of 17,139 shares — an estimated $164K sold.

MML Investors Services first reported a position in EBS in Q4 2018 and held it in 10 quarters. The position peaked at $442K in Q3 2020. 160 funds tracked by Wall St. Rank hold EBS as of Q1 2025.

  • MML Investors Services reported no remaining Emergent Biosolutions position as of Q1 2025 after selling out during the quarter.
  • MML Investors Services sold 17,139 Emergent Biosolutions shares in Q1 2025, an estimated $164K.
  • MML Investors Services first reported a position in Emergent Biosolutions in Q4 2018 and held it in 10 quarters.
  • MML Investors Services's Emergent Biosolutions position peaked at $442K in Q3 2020.
  • 160 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q1 2025.

Based on MML Investors Services's 13F filing for Q1 2025, filed 14 May 2025.